ArticleFrontiers in cardiovascular medicine2026
A study on the correlation between novel inflammatory indices and severity of coronary artery lesions in patients with stable coronary artery disease.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: The novel inflammatory indices integrate information from multiple immune cells, but their application in stable coronary artery disease (SCAD) remains limited. This research aims to explore the association between the novel inflammatory indices and the degree of coronary artery lesions in SCAD patients. Methods: This retrospective analysis involved 2,424 patients of SCAD who received coronary angiography at Beijing Hospital from January 2021 to January 2024. Participants were assigned to groups with mild and severe coronary artery lesions according to the Gensini score. Based on whole blood cell parameters, we calculated the neutrophil-lymphocyte ratio (NLR), monocyte-lymphocyte ratio (MLR), platelet-lymphocyte ratio (PLR), systemic immune inflammation index (SII), systemic inflammatory response index (SIRI), and systemic immune inflammatory response index (SIIRI) and analyzed their links to the degree of coronary artery lesions. Results: All novel inflammatory indices exhibited positive associations with the Gensini score ( Conclusion: NLR, MLR, and SIRI demonstrate notable associations with the extent of coronary artery lesions in individuals with SCAD and can be used as non-invasive risk assessment indicators. This research provides novel perspectives for the study of inflammatory mechanisms and risk assessment of SCAD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.